Terufumi Kubo

Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients

Kazunari Sugita, Catherine A. Steer, Itziar Martínez-González et al. · Journal of Allergy and Clinical Immunology · 2017 · 259 citations

Asthma, Cytokine, Allergy +10

Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid

Hideaki Morita, Terufumi Kubo, Beate Rückert et al. · Journal of Allergy and Clinical Immunology · 2019 · 166 citations

Inflammation, Group 2, Cell Regulation +10

Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy

Rena Morita, Yoshihiko Hirohashi, Toshihiko Torigoe et al. · Clinical Cancer Research · 2016 · 85 citations

Preferential expression of cancer/testis genes in cancer stem‐like cells: proposal of a novel sub‐category, cancer/testis/stem gene

Ryoichi Yamada, Akiko Takahashi, Toshihiko Torigoe et al. · Tissue Antigens · 2013 · 81 citations

Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report

Osamu Honjo, Terufumi Kubo, Fumiko Sugaya et al. · Journal for ImmunoTherapy of Cancer · 2019 · 72 citations · Full text